GE HealthCare: Novii+ Wireless Maternal and Fetal Monitoring Solution Cleared by the FDA for Monitoring Approximately 95% of All Eligible Births in the United States
February 03, 2024
February 03, 2024
CHICAGO, Illinois, Feb. 3 -- GE HealthCare, a subsidiary of General Electric, issued the following news release on Feb. 1, 2024:
* * *
* GE HealthCare receives FDA clearance for expanded indication for Novii+ maternal and fetal monitoring solution for pregnant patients 34 weeks.[i]
* Novii+ noninvasively measures and displays fetal heart rate, maternal heart rate and uterine activity, while providing patient comfort and mobility in the hospital.
* * *
* GE HealthCare receives FDA clearance for expanded indication for Novii+ maternal and fetal monitoring solution for pregnant patients 34 weeks.[i]
* Novii+ noninvasively measures and displays fetal heart rate, maternal heart rate and uterine activity, while providing patient comfort and mobility in the hospital.